Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMK8P61)

Drug Name

Tetradecane Drug Info

Synonyms

629-59-4; N-TETRADECANE; Alkanes, C14-16; Tridecane, methyl-; CCRIS 715; Tetradecane, 99%; UNII-03LY784Y58; HSDB 5728; EINECS 211-096-0; NSC 72440; C14H30; BRN 1733859; AI3-04240; CHEBI:41253; BGHCVCJVXZWKCC-UHFFFAOYSA-N; MFCD00008986; 03LY784Y58; 90622-46-1; Tetradecane, analytical standard; Alkanes, C14-30; Tetradekan; n-Teradecane; Tetradecane olefine; EINECS 292-448-0; Paraffinic hydrocarbons (C14-C30); Tetradecane, > AC1L1ZHO; DSSTox_CID_7267; EC 211-096-0; DSSTox_RID_78378; ACMC-1B07Q; DSSTox_GSID_27267

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

PubChem CID: 12389
ChEBI ID: CHEBI:41253
CAS Number: CAS 629-59-4
TTD Drug ID: DMK8P61

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Discontinued Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Lanosterol synthase (LSS)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ZD-9720	DMFV47R	Arteriosclerosis	BD40	Terminated	[2]
BIBB-515	DM6QT9P	Arteriosclerosis	BD40	Terminated	[3]
BIBX-79	DMRXWCO	Arteriosclerosis	BD40	Terminated	[4]
B-Octylglucoside	DMMO75G	Discovery agent	N.A.	Investigative	[1]
Lanosterol	DMHN74V	Discovery agent	N.A.	Investigative	[1]
PMID22533316C1	DMYEMWB	Discovery agent	N.A.	Investigative	[5]
PMID22533316C4	DMW3UHO	Discovery agent	N.A.	Investigative	[5]
PMID9003518C4	DMYE64O	Discovery agent	N.A.	Investigative	[6]
29-methylidene-2,3-oxidosqualene	DMUQAP7	Discovery agent	N.A.	Investigative	[6]
PMID9003518C3	DM1I578	Discovery agent	N.A.	Investigative	[6]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Lanosterol synthase (LSS)	TT7O8ZA	ERG7_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
2	Toxicologic lesions associated with two related inhibitors of oxidosqualene cyclase in the dog and mouse. Toxicol Pathol. 2001 Mar-Apr;29(2):174-9.
3	Effects of a novel 2,3-oxidosqualene cyclase inhibitor on cholesterol biosynthesis and lipid metabolism in vivo. J Lipid Res. 1997 Mar;38(3):564-75.
4	Effects of a novel 2,3-oxidosqualene cyclase inhibitor on the regulation of cholesterol biosynthesis in HepG2 cells. J Lipid Res. 1996 Jan;37(1):148-58.
5	Cytotoxic effects of combination of oxidosqualene cyclase inhibitors with atorvastatin in human cancer cells. J Med Chem. 2012 Jun 14;55(11):4990-5002.
6	Synthesis and inhibition studies of sulfur-substituted squalene oxide analogues as mechanism-based inhibitors of 2,3-oxidosqualene-lanosterol cyclase. J Med Chem. 1997 Jan 17;40(2):201-9.